9 months ago
CRVO
AnalystsSoumit RoySoumit Roy's Stock Forecasts
AnalystsSoumit Roy
Sectors:
Analyst Ranking
Top 24%
#1221 out of 5150 analysts
Average Return
+6.01%
Win Rate
31%11 out of 35
Risk vs Reward
Poor
Good
Soumit Roy's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Monopar TherapeuticsMNPR | +727.79% | $3.85 | $31.87 | 2024-04-11 - 2025-04-10 | Strong Buy |
Nuvation Bio IncNUVB | +276.34% | $2.24 | $8.43 | 2025-03-12 - 2025-12-12 | Strong Buy |
Elicio Therapeutics IncELTX | +117.14% | $4.26 | $9.25 | 2024-10-31 - 2025-10-30 | Strong Buy |
Cullinan Therapeutics IncCGEM | +86.53% | $8.76 | $16.34 | 2023-10-06 - 2024-10-04 | Strong Buy |
Protara Therapeutics IncTARA | +79.81% | $3.17 | $5.70 | 2025-05-22 - 2025-12-12 | Strong Buy |
Soumit Roy Analyst Color
Get additional color on Soumit Roy's coverage of popular stocks
Soumit Roy's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Evaxion AEVAX | 1 | Strong Buy | $10.00 | +61.03% | Initiates Coverage On | 2 months ago |
Cg Oncology IncCGON | 1 | Strong Buy | $50.00 | +22.13% | Initiates Coverage On | 3 months ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $21.00 | +268.42% | Initiates Coverage On | 7 months ago |
Arrivent Biopharma IncAVBP | 1 | Strong Buy | $40.00 | +63.80% | Initiates Coverage On | 7 months ago |
Enliven Therapeutics IncELVN | 2 | Strong Buy | $27.00 | +60.14% | Maintains | 7 months ago |
Cervomed IncCRVO | 2 | Strong Buy | $15.00 | +77.51% | Upgrades | 9 months ago |
Nuvation Bio IncNUVB | 1 | Strong Buy | $10.00 | +18.62% | Initiates Coverage On | 9 months ago |
Beam Therapeutics IncBEAM | 1 | Strong Buy | $34.00 | +24.27% | Upgrades | 9 months ago |
Chimerix IncCMRX | 1 | Hold | $8.55 | +0.12% | Downgrades | 9 months ago |
In8bio IncINAB | 3 | Strong Buy | $36.00 | +2,042.86% | Upgrades | 10 months ago |
Onkure Therapeutics IncOKUR | 1 | Strong Buy | $32.00 | +942.35% | Initiates Coverage On | a year ago |
Mural Oncology PLCMURA | 1 | Strong Buy | $16.00 | +684.31% | Initiates Coverage On | a year ago |
Elicio Therapeutics IncELTX | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | a year ago |
Oric Pharmaceuticals IncORIC | 1 | Strong Buy | $17.00 | N/A | Initiates Coverage On | a year ago |
Editas Medicine IncEDIT | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | a year ago |
Adicet Bio IncACET | 2 | Strong Buy | $4.00 | N/A | Maintains | a year ago |
Deciphera Pharmaceuticals IncDCPH | 1 | Hold | $25.60 | N/A | Downgrades | 2 years ago |
Cullinan Therapeutics IncCGEM | 2 | Strong Buy | $26.00 | N/A | Maintains | 2 years ago |
Janux Therapeutics IncJANX | 1 | Strong Buy | $70.00 | N/A | Initiates Coverage On | 2 years ago |
Monopar TherapeuticsMNPR | 2 | Strong Buy | $10.00 | N/A | Upgrades | 2 years ago |
Acrivon Therapeutics IncACRV | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 2 years ago |
Oncolytics Biotech IncONCY | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 3 years ago |
Coeptis Therapeutics Holdings IncCOEP | 1 | Strong Buy | $80.00 | N/A | Initiates Coverage On | 3 years ago |
Inhibikase Therapeutics IncIKT | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Hcw Biologics IncHCWB | 1 | Strong Buy | $320.00 | N/A | Initiates Coverage On | 3 years ago |
Aveo Pharmaceuticals IncAVEO | 1 | Hold | $15.00 | N/A | Downgrades | 3 years ago |
Rain Oncology IncRAIN2 | 1 | Strong Buy | $17.00 | N/A | Initiates Coverage On | 3 years ago |
Ars Pharmaceuticals IncSPRY | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Tracon Pharmaceuticals IncTCON | 1 | Strong Buy | $340.00 | N/A | Initiates Coverage On | 5 years ago |
Celyad Oncology SaCYADY | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Cassava Sciences IncSAVA | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 5 years ago |
Precision Biosciences IncDTIL | 1 | Strong Buy | $810.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.